CLINICAL_TRIALS
trial_result
· 2025-05-04
Clinical Trial Update: A Study of ANAVEX3-71 in Adults With Schizophrenia [Phase 2]
Summary
An update on a Phase 2 study of ANAVEX3-71 in adults with schizophrenia, noting that the trial is currently ACTIVE_NOT_RECRUITING.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anavex Life Sciences Corp. | Conditions: Schizophrenia | Phase 2 | Status: ACTIVE_NOT_RECRUITING